Showing results (531-540 of 1,028) with videos related to
Sort By:
Pageof 103
Practical Laboratory Medicine|January 19, 2026
Evaluating extraction-free PCR for rapid detection of beta-lactam antibiotic resistance in urinary tract infectionSadia Almas, Rob E Carpenter, Vaibhav K Tamrakar, et al.Journal of the American College of Cardiology|July 4, 2015
Cardiac Arrest: A Treatment Algorithm for Emergent Invasive Cardiac Procedures in the Resuscitated Comatose PatientTanveer Rab, Karl B Kern, Jacqueline E Tamis-Holland, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 9, 2017
The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS studyMark B Effron, Tracy Y Wang, Gregg C Fonarow, et al.The American Journal of Cardiology|October 15, 2003
Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trialsDerek P Chew, Deepak L Bhatt, William Kimball, et al.Preventing Chronic Disease|October 19, 2011
The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008James M Peacock, Hong H Keo, Sue Duval, et al.Circulation|September 28, 2011
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudicationMark A Creager, Jeffrey W Olin, Jill J F Belch, et al.American Heart Journal|November 12, 2019
Admission Society for Cardiovascular Angiography and Intervention shock stage stratifies post-discharge mortality risk in cardiac intensive care unit patientsJacob C Jentzer, David A Baran, Sean van Diepen, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 1, 2013
New generation drug-eluting stents for ST-elevation myocardial infarction: a new paradigm for safetyAnkit Garg, Bruce R Brodie, Thomas D Stuckey, et al.Stem Cells Translational Medicine|June 13, 2020
CD34+ cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory anginaGrace L Johnson, Timothy D Henry, Thomas J Povsic, et al.Circulation. Cardiovascular Quality and Outcomes|June 4, 2015
Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyRobin Mathews, Eric D Peterson, Emily Honeycutt, et al.Pageof 103